Homering M[Author] - Search Results

Year	Number of Results
2004	2
2005	3
2007	3
2009	1
2010	1
2011	2
2012	3
2013	2
2014	3
2018	2
2024	1

1

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Brobert G, Ruigomez A, Schink T, Voss A, Herings R, Smits E, Swart KMA, Friberg L, Balabanova Y, Tarenz C, Suzart-Woischnik K, Soriano-Gabarró M, Vora P, Homering M, Dyszynski T, Nagel G, Amaya P, García Rodríguez LA. Brobert G, et al. Among authors: homering m. BMJ Open. 2024 Mar 25;14(3):e081348. doi: 10.1136/bmjopen-2023-081348. BMJ Open. 2024. PMID: 38531587 Free PMC article. Review.

2

Risk of recurrent venous thromboembolism according to baseline risk factor profiles.

Prins MH, Lensing AWA, Prandoni P, Wells PS, Verhamme P, Beyer-Westendorf J, Bauersachs R, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Kakkar AK, van Bellen B, Pap AF, Homering M, Tamm M, Weitz JI. Prins MH, et al. Among authors: homering m. Blood Adv. 2018 Apr 10;2(7):788-796. doi: 10.1182/bloodadvances.2018017160. Blood Adv. 2018. PMID: 29632234 Free PMC article. Clinical Trial.

3

Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.

Prandoni P, Lensing AWA, Prins MH, Gebel M, Pap AF, Homering M, Bauersachs R, Beyer-Westendorf J, Bounameaux H, Cohen AT, Davidson BL, van Bellen B, Verhamme P, Wells PS, Yuan Z, Levitan B, Weitz JI. Prandoni P, et al. Among authors: homering m. Thromb Res. 2018 Aug;168:121-129. doi: 10.1016/j.thromres.2018.06.009. Epub 2018 Jul 10. Thromb Res. 2018. PMID: 30064683

4

Complication rates after hip or knee arthroplasty in morbidly obese patients.

Friedman RJ, Hess S, Berkowitz SD, Homering M. Friedman RJ, et al. Among authors: homering m. Clin Orthop Relat Res. 2013 Oct;471(10):3358-66. doi: 10.1007/s11999-013-3049-9. Epub 2013 May 14. Clin Orthop Relat Res. 2013. PMID: 23670675 Free PMC article.

5

Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin).

Rosencher N, Llau JV, Mueck W, Loewe A, Berkowitz SD, Homering M. Rosencher N, et al. Among authors: homering m. Acta Anaesthesiol Scand. 2013 May;57(5):565-72. doi: 10.1111/aas.12069. Epub 2013 Jan 21. Acta Anaesthesiol Scand. 2013. PMID: 23336294 Clinical Trial.

6

Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty.

Friedman R, Homering M, Holberg G, Berkowitz SD. Friedman R, et al. Among authors: homering m. J Bone Joint Surg Am. 2014 Feb 19;96(4):272-8. doi: 10.2106/JBJS.L.01268. J Bone Joint Surg Am. 2014. PMID: 24553882

7

The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.

Lassen MR, Gent M, Kakkar AK, Eriksson BI, Homering M, Berkowitz SD, Turpie AG. Lassen MR, et al. Among authors: homering m. J Bone Joint Surg Br. 2012 Nov;94(11):1573-8. doi: 10.1302/0301-620X.94B11.28955. J Bone Joint Surg Br. 2012. PMID: 23109641 Free article.

8

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.

Eriksson BI, Kakkar AK, Turpie AG, Gent M, Bandel TJ, Homering M, Misselwitz F, Lassen MR. Eriksson BI, et al. Among authors: homering m. J Bone Joint Surg Br. 2009 May;91(5):636-44. doi: 10.1302/0301-620X.91B5.21691. J Bone Joint Surg Br. 2009. PMID: 19407299 Free article. Clinical Trial.

9

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.

Fisher WD, Eriksson BI, Bauer KA, Borris L, Dahl OE, Gent M, Haas S, Homering M, Huisman MV, Kakkar AK, Kälebo P, Kwong LM, Misselwitz F, Turpie AG. Fisher WD, et al. Among authors: homering m. Thromb Haemost. 2007 Jun;97(6):931-7. Thromb Haemost. 2007. PMID: 17549294

10

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.

Levitan B, Yuan Z, Turpie AG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM. Levitan B, et al. Among authors: homering m. Vasc Health Risk Manag. 2014 Mar 26;10:157-67. doi: 10.2147/VHRM.S54714. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24707185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year